RED QUEEN THERAPEUTICS
RED QUEEN THERAPEUTICS
Industry:
Biotechnology Medical
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Status:
Active
Contact:
203-232-7865
Total Funding:
5 M USD
Similar Organizations
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
Current Employees Featured
More informations about "Red Queen Therapeutics"
Red Queen Therapeutics
Red Queen Therapeutics is a clinical-stage company working to deliver important and accessible treatment options for a broad range of virus-borne illnesses including influenzas, coronaviruses, and other current and emerging pathogens.See details»
Red Queen Therapeutics - Crunchbase Company …
Red Queen Therapeutics is a biotech company that works in the fields of medicine, agriculture, crop production, non-food use of crops, and heavy industry. They generally research, develop, and produce a variety of commercial …See details»
Red Queen Therapeutics - LinkedIn
Red Queen Therapeutics is a clinical-stage company working to deliver important and accessible new treatment options for a broad range of virus-borne illnesses including influenzas,...See details»
Apple Tree Partners | Apple Tree Partners Launches Red...
Aug 6, 2024 · Apple Tree Partners (ATP), a leader in life sciences venture capital, today unveiled Red Queen Therapeutics, a clinical-stage biotechnology company developing novel antiviral …See details»
Red Queen launches to tackle viral infections
Aug 6, 2024 · Red Queen Therapeutics, a new clinical-stage biotechnology company, has launched with a mission to develop antiviral treatments for serious viral diseases, including coronaviruses, influenza, and respiratory syncytial …See details»
New start-up aims to turn stapled peptides into antivirals
Aug 6, 2024 · Red Queen Therapeutics launched Tuesday with $55 million in venture backing, a contract with the Biomedical Advanced Research and Development Authority (BARDA), and a pipeline led by a drug candidate that …See details»
Biotech Red Queen launches with $55M to build versatile antivirals
Aug 6, 2024 · Permission granted by Red Queen Therapeutics Venture firm Apple Tree Partners has invested $55 million in a new biotechnology company developing antiviral treatments …See details»
Apple Tree Partners Launches Red Queen Therapeutics to Bring
Aug 6, 2024 · Apple Tree Partners (ATP), a leader in life sciences venture capital, today unveiled Red Queen Therapeutics, a clinical-stage biotechnology company developing novel antiviral …See details»
Red Queen Company Profile 2024: Valuation, Funding & Investors
Developer of biotechnology drugs intended to prepare rapid responses to current and emerging pathogens that threaten human health and life.See details»
Red Queen Therapeutics - VentureRadar
Red Queen Therapeutics is a clinical-stage biotechnology company preparing rapid responses to current and emerging pathogens that threaten human health and life. Our novel plug-and-play …See details»
Red Queen Therapeutics - Funding, Financials, Valuation & Investors
Red Queen Therapeutics is a biotechnology company.See details»
BioCentury - Red Queen: A new approach to viral fusion proteins
Oct 28, 2024 · Red Queen Therapeutics Inc. is developing small molecules that inhibit viral fusion to stop entry into host cells, an approach it's applying to at least four viral families. Its lead …See details»
Apple Tree Partners Launches Red Queen Therapeutics to Bring ...
Aug 6, 2024 · Apple Tree Partners (ATP), a leader in life sciences venture capital, today unveiled Red Queen Therapeutics, a clinical-stage biotechnology company developing novel antiviral …See details»
Red Queen Therapeutics - Contacts, Employees, Board
Red Queen Therapeutics has 1 current employee profile, Founder and CEO Jimmy Dibra. Red Queen Therapeutics has 5 board members and advisors, including Seth Harrison.See details»
Red Queen Therapeutics: $55 Million (Series A) Closed To Develop …
Apple Tree Partners (ATP) – a leader in life sciences venture capital – has unveiled Red Queen Therapeutics, a clinical-stage biotechnology company developing novel antiviral treatments for …See details»
Red Queen targets infections with predatory lipopeptides
Aug 6, 2024 · Armed with $55 million in series A funds and a U.S. government contract, Cambridge, Mass.-based Red Queen Therapeutics Inc. launched operations this week, with …See details»
Apple Tree Partners Launches Red Queen Therapeutics to Bring ...
Aug 6, 2024 · Red Queen uses a novel antiviral platform to create pan-variant treatments for coronaviruses, influenza, RSV, and other serious viral diseases, with recent clinical validation …See details»
Red Queen borne by Apple Tree Partners | Pharmaceutical | The ...
Aug 6, 2024 · Life sciences venture capital company Apple Tree Partners (ATP) has unveiled Red Queen Therapeutics, a biotech developing antivirals for the general population and especially …See details»
Stapled lipopeptides show promise as broad-spectrum antiviral …
Jan 5, 2024 · Then, in partnership with the laboratory of Richard Bowen, DVM, PhD, of Colorado State University and the newly formed Red Queen Therapeutics of Cambridge, Massachusetts …See details»
RQ-001 in COVID-19 and Infectious Disease and SARS CoV 2
Sep 17, 2023 · Adult patients who have tested positive for SARS-CoV-2 virus, have mild symptom (s) of COVID-19 disease, and who are at low risk for developing moderate or severe COVID …See details»